Stock B1AX34 BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Baxter International Inc. Sao Paulo

Equities

B1AX34

BRB1AXBDR004

Market Closed - Sao Paulo
Other stock markets
 12:18:42 06/07/2024 am IST 		5-day change 1st Jan Change
93.78 BRL +0.58% Intraday chart for Baxter International Inc. +0.58% -1.12%
10/07 Citigroup Adjusts Price Target on Baxter International to $37 From $38 MT
08/07 Sector Update: Financial Stocks Advance Premarket Monday MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Baxter International : Issues Urgent Medical Device Recall for Life2000 Ventilator Due to Potential Battery Charger Dongle Damage
PU
Baxter International : 2023 SASB Index
PU
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
BU
Baxter International : 2023 Corporate Responsibility Report2022 Corporate Responsibility Report2022 Task Force for Climate-related Financial Disclosures (TCFD) Index2021 Corporate Responsibility Report
PU
Fitch Affirms and Withdraws Baxter's Ratings
AQ
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
BU
New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years
AQ
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
BU
Baxter to Present at Jefferies 2024 Global Healthcare Conference
BU
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
BU
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
BU
Baxter to Present at Bank of America 2024 Health Care Conference
BU
Baxter Declares Quarterly Dividend
BU
Baxter International : Q1 2024 Financial Schedules
PU
Baxter: Q1 Earnings Snapshot
AQ
Baxter Reports First-Quarter 2024 Results
BU
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO
AQ
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
BU
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
BU
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. B1AX34 Stock
  5. News Baxter International Inc.
  6. Press Releases